CN209122887U - A kind of infusion bottle of achievable vitro Drug isolation - Google Patents
A kind of infusion bottle of achievable vitro Drug isolation Download PDFInfo
- Publication number
- CN209122887U CN209122887U CN201721452784.7U CN201721452784U CN209122887U CN 209122887 U CN209122887 U CN 209122887U CN 201721452784 U CN201721452784 U CN 201721452784U CN 209122887 U CN209122887 U CN 209122887U
- Authority
- CN
- China
- Prior art keywords
- baffle
- isolating device
- medicine cavity
- achievable
- isolation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
The utility model discloses a kind of infusion bottles of achievable vitro Drug isolation, belong to technical field of medical equipment, medicine cavity side is converted inside the isolating device equipped with elastic membrane, is equipped with barbed baffle rinsing chamber side, there is through-hole on the baffle, the thorn on the baffle is directed toward elastic membrane.The utility model can solve drug mixing adverse effect caused by sufferer, have advantage simple in sturcture, ingenious in design, at low cost.
Description
Technical field
The utility model relates to technical field of medical equipment, in particular to a kind of achievable vitro Drug isolation
Infusion bottle.
Background technique
Venous transfusion is clinical most important administration route, is so that drug is reached fast in vivo by being administered in vein blood vessel
Speed absorbs, and is the most common treatment means, the especially critical moment in rescue urgent patient in the effective treatment disease of one kind,
Venous access is opened, gaining time for treatment patient, it is energetically immeasurable to play the role of.However there is also one for venous transfusion
Determine medical security risks, due to the adverse reaction that many-sided, too many levels factor occurs patient in infusion also show it is more
Kind of multiplicity, there is pathological lesion in some patientss intravenous site, but clinically it is more common be morbidity suddenly, reflection
Strongly, involve the general reaction of a variety of internal organs of whole body.How correctly to recognize, handle in time, patient is very important, now will
The adverse reaction and precautionary measures for being infused common are analyzed as follows.Exothermic reaction: be in infusion process the unexpected chilly of patient, not from
Main to tremble, switch to high fever, serious cyanosis, pale complexion rapidly, severe one heart rate is fast, the thin speed of arteries and veins, collapse, and exothermic reaction is that infusion is anti-
Middle one of the most common type is answered, more typical reason has pyrogen germ or other substance contaminated fluids and transfusion article, because of drug
Impure or drug has caused by incompatibility.
Allergic reaction: being that patient flushed face, nettle rash, whole body itch occurs.Severe one is uncomfortable in chest, generates heat, lip cyanosis, this
When should be noted that shock, such as rescue not in time may threat to life.More typical reason has anaphylactogen to enter human body initiation, drug
Caused by impure and/or drug incompatibility.
The incompatibility of drug refers to phase when two or more drug is used in mixed way or is made preparation outside generating body
Interaction occurs making the physical and chemical reactions such as drug neutralization, hydrolysis, damage inactivation, this is that muddy, precipitating possible occur, generate gas
Etc. adverse consequences.The consequence that chemical incompatibility generates in the incompatibility of drug is particularly acute, and cannot not only be generated and be controlled
Disease rescues the effect of people, can generate toxicant harm health instead.
Utility model content
The purpose of this utility model is to provide a kind of infusion bottles of achievable vitro Drug isolation, are inputting two kinds of differences
A phase buffer is given among drug, therefore the solvent of drug packaging is given and is improved, to reach reduction or even prevent such
The generation of adverse reaction.
To realize the utility model aim, the technical solution of use are as follows: a kind of infusion bottle of achievable vitro Drug isolation,
Including bottle body, which is characterized in that be equipped with the barrier tape for being divided into infusion bottle and rinsing chamber, converting medicine cavity, the resistance in the bottle body
It is equipped with isolating device every band lower part, the isolation and connection rinsed chamber, convert medicine cavity, the isolation dress may be implemented in the isolating device
Be set to tubular, the opening at both ends respectively with rinse chamber, convert medicine cavity connection, medicine cavity side is converted inside the isolating device and is equipped with elasticity
Film is equipped with barbed baffle rinsing chamber side, has through-hole on the baffle, the thorn on the baffle is directed toward elastic membrane;It is described
The bottom for rinsing chamber is equipped with liquid outlet, and the bottom for converting medicine cavity is equipped with and converts medicine mouth.
Further, the isolating device both ends are equipped with arc panel with holes.
The utility model has the beneficial effects that being directed to the defect of existing infusion bottle, the bag body of infusion bottle is divided into two
Independent cavity, and a channel that can be opened and closed is equipped with below two independent cavitys, in the factory of bottled physiological saline,
We toward rinsing chamber, converting in medicine cavity filling physiological saline until elastic membrane is heaved, convert the pressure in medicine cavity and are equal to flushing chamber simultaneously,
Elastic membrane in isolating device will not deform;When in use, it is infused since liquid outlet, within a period of time originally, enters
Human body is the physiological saline for not converted medicine, is rinsing intracavitary liquid level decline, pressure difference makes elastic membrane deformation, by side
Spine on baffle punctures, and two chamber connection, the liquid for blending medicament for converting medicine cavity initially enters human body.
Detailed description of the invention
Fig. 1 is the structural schematic diagram that the infusion bottle of vitro Drug isolation can be achieved;
Fig. 2 is isolating device enlarged structure schematic diagram.
Specific embodiment
The utility model is further described in detail below through specific implementation examples and in conjunction with the accompanying drawings.
Fig. 1, Fig. 2 shows the infusion bottle of achievable vitro Drug isolation provided by the utility model, including bottle body 1, bottles
Body 1 uses glass material, is equipped in bottle body 1 for infusion bottle to be divided into and rinses left side cavity in chamber 3(Fig. 1), convert medicine cavity 9(Fig. 1
Middle right side cavity) barrier tape 2, barrier tape 2 is integrally to form with bottle body 1;2 lower part of barrier tape is equipped with isolating device 4, barrier dress
Set 4 amplification such as Fig. 2, isolation, which fills 4, may be implemented the isolation and connection rinsing chamber 3, convert medicine cavity 9, and isolating device 4 is at tubular, and two
The opening at end respectively with rinse chamber 3, convert 9 connection of medicine cavity, 9 side of medicine cavity is converted inside isolating device 4 equipped with elastic membrane 10, is being rinsed
3 side of chamber is equipped with barbed baffle 11, has through-hole on baffle 11, the property film that the thorn 12 on baffle 11 is positioned close to that
Side;The bottom for rinsing chamber 3 is equipped with liquid outlet 5, and the bottom for converting medicine cavity 9, which is equipped with, converts medicine mouth 6.Bottom mentioned here, which refers to, is being infused
The normal operating condition of bottle, is not storage configuration.
Further, for the pressure oscillation that the vortex reduced in two chambers generates, 4 both ends of isolating device are equipped with holes
8 arc panel 7.
The above descriptions are merely preferred embodiments of the present invention, is not intended to limit the utility model, for this
For the technical staff in field, there can be various modifications and variations in the spirit and principles of the utility model, these are equivalent
Variation or replacement etc., are included in the protection scope of the present invention.
Claims (2)
1. a kind of infusion bottle of achievable vitro Drug isolation, including bottle body, which is characterized in that being equipped in the bottle body will be infused
The barrier tape that bottle is divided into and rinses chamber, converts medicine cavity, the barrier tape lower part are equipped with isolating device, and the isolating device may be implemented
Rinse chamber, convert the isolation and connection of medicine cavity, the isolating device at tubular, the opening at both ends respectively with rinse chamber, convert medicine cavity connection
It is logical, medicine cavity side is converted inside the isolating device equipped with elastic membrane, barbed baffle is equipped with rinsing chamber side, on the baffle
There is through-hole, the thorn on the baffle is directed toward elastic membrane;The bottom for rinsing chamber is equipped with liquid outlet, and the bottom for converting medicine cavity is set
Convert medicine mouth.
2. the infusion bottle of achievable vitro Drug isolation according to claim 1, which is characterized in that the isolating device two
End is equipped with arc panel with holes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201721452784.7U CN209122887U (en) | 2017-11-03 | 2017-11-03 | A kind of infusion bottle of achievable vitro Drug isolation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201721452784.7U CN209122887U (en) | 2017-11-03 | 2017-11-03 | A kind of infusion bottle of achievable vitro Drug isolation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN209122887U true CN209122887U (en) | 2019-07-19 |
Family
ID=67226487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201721452784.7U Active CN209122887U (en) | 2017-11-03 | 2017-11-03 | A kind of infusion bottle of achievable vitro Drug isolation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN209122887U (en) |
-
2017
- 2017-11-03 CN CN201721452784.7U patent/CN209122887U/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hardaway et al. | Treatment of severe acute respiratory distress syndrome: a final report on a phase I study | |
Veljković et al. | Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia | |
Lewisohn et al. | Prevention of chills following transfusion of citrated blood | |
CN209122887U (en) | A kind of infusion bottle of achievable vitro Drug isolation | |
CN207125897U (en) | A kind of infusion bottle with automatic flushing function | |
Saravu et al. | Near-fatal amlodipine poisoning. | |
CN202314363U (en) | Transfusion bag with tube washing function | |
CN208114809U (en) | A kind of band opens the liquid liquid double-chamber transfusion bag on side | |
Levy et al. | Peripheral intravenous infusion—another cause of air embolism | |
CN105944118A (en) | Medicinal disinfection ultrasonic coupling agent and preparation method thereof | |
SCHALL | TREATMENT OF SEPTIC THROMBOPHLEBITIS OF THE CAVERNOUS SINUS: CHAIRMAN'S ADDRESS | |
RU2363420C2 (en) | Method of hemosorption in dogs | |
Smith et al. | Intracardiac air-the" hospital killer'identified? | |
RU2659632C1 (en) | Device for foaming and administering a medicament | |
Gold et al. | The rationale of intra-arterial transfusion with a case report. | |
JP4802492B2 (en) | Prefilled syringe preparation containing heparin | |
Cunningham et al. | The role of fibrinolytic agents in the management of thrombotic complications associated with vascular access devices | |
CN109330979A (en) | Fluorine carbon oxygen carrying emulsion and preparation method thereof | |
TWI687245B (en) | Infusion cannula | |
CN109045381A (en) | Special pipeline pre-charging circulating device for ECMO and application thereof | |
Lindeman | Reactions following blood transfusion by the syringe cannula system | |
Hasskarl et al. | Complete caval thrombosis secondary to an implanted venous port–a case study | |
Philpott et al. | Automated method for exchange transfusion | |
Bocci et al. | The Actual Six Therapeutic Modalities | |
CN208809065U (en) | The non-disposable washing pipe type infusion bag of PVC |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant |